Dynavax Technologies Corporation

13.29 USD
-0.02 (-0.15%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Dynavax Technologies Corporation stock is up 1.53% since 30 days ago. The next earnings date is Feb 22, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 19 December’s closed higher than November. In the last 2 Unusual Options Trades, there were 2 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
10 Oct 14:25 19 Jan, 2024 5.00 CALL 30 97
16 Oct 14:34 17 Nov, 2023 14.00 CALL 340 458

About Dynavax Technologies Corporation

The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in the vaccine. The company was formerly known as Double Helix Corporation.